In 2018, the global translational regenerative medicine is estimated at $28bn. The global translational regenerative medicine market is highly competitive and fragmented with the presence of several vendors. The competition is likely to increase with advances in R&D and technological innovations. The market is characterized by the presence of well-diversified international and local vendors that provide cost-effective products with limited features and functionalities.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you will find 230-page report and you will receive 120 tables and 70 figures – all unavailable elsewhere.

The 230-page report provides clear detailed insight into the Top 25 Translational Regenerative Medicine Manufacturers 2019. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
This report discusses the global translational regenerative medicine market and provides revenue forecast to 2028 for this market and its leading submarkets:

  • Stem Cells
  • Tissue Engineering
  • Gene Therapy

This report discusses several translational regenerative medicine products and provides revenue forecast to 2028 for:

  • Osteocel Plus
  • Apligraf
  • Grafix/Stravix
  • ReCell

Assessment of the 25 leading manufacturers in the global translational regenerative medicine market:

  • Acelity
  • Alphatec Spine
  • Anika Therapeutics
  • Arthesys
  • Avita Medical
  • Integra Lifesciences
  • Medipost
  • Medtronic
  • Mesoblast
  • NuVasive
  • Organogenesis
  • Orthofix International
  • TiGenix
  • UniQure
  • Vericel Corporation
  • Other companies

This report discusses product portfolio, key developments, financial information, performance analysis, revenue forecast and pipeline analysis.

Of the top 25 translational regenerative medicine manufacturers, the report provides revenue forecast for 22 of these companies for the period of 2018 to 2028.

Qualitative analysis of the translational regenerative medicine market: PESTEL analysis, Porter’s Five Forces analysis, factors that drive and restrain the market, opportunity and trends in the market.

This report discusses the regulation of regenerative medicine in the US, Japan, China, Australia, India and Ireland.

Key questions answered by this report:

  • Who are the leading Translational Regenerative Medicine (TRM) manufacturers?
  • What factors are driving and restraining the growth of these leading TRM manufacturers?
  • How have the leading TRM manufacturers performed financially in recent years?
  • Which TRM manufacturer will experience revenue growth over the coming years?
  • What strategies have TRM manufacturers been implementing for sales growth in recent years?
  • Which technologies will be crucial to TRM manufacturers from 2018 to 2028?